Working… Menu

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04517149
Recruitment Status : Recruiting
First Posted : August 18, 2020
Last Update Posted : June 15, 2021
Information provided by (Responsible Party):
4D Molecular Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2023
Estimated Study Completion Date : September 2023